We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

36 hedge funds and large institutions have $14.7M invested in AIM ImmunoTech in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

3% more funds holding

Funds holding: 35 → 36 (+1)

5% less capital invested

Capital invested by funds: $15.5M → $14.7M (-$746K)

Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
12
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$468K
2
Millennium Management
Millennium Management
New York
+$110K
3
Verition Fund Management
Verition Fund Management
Connecticut
+$81.8K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$73.1K
5
WG
Winton Group
United Kingdom
+$55.9K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$329K
2
Morgan Stanley
Morgan Stanley
New York
-$249K
3
XT
XTX Topco
Cayman Islands
-$63K
4
HighTower Advisors
HighTower Advisors
Illinois
-$52.7K
5
Charles Schwab
Charles Schwab
California
-$44K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$4.82M -$249K -1,231 -5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$4.05M +$19.8K +98 +0.5%
BlackRock
3
BlackRock
New York
$1.67M +$11.1K +55 +0.7%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$753K +$42.8K +212 +6%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$749K +$468K +2,317 +166%
BCM
6
Bridgeway Capital Management
Texas
$477K -$20.2K -100 -4%
State Street
7
State Street
Massachusetts
$324K – – –
Verition Fund Management
8
Verition Fund Management
Connecticut
$300K +$81.8K +405 +37%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$236K – – –
Northern Trust
10
Northern Trust
Illinois
$179K +$2.42K +12 +1%
WG
11
Winton Group
United Kingdom
$167K +$55.9K +277 +50%
Millennium Management
12
Millennium Management
New York
$110K +$110K +544 New
RJFSA
13
Raymond James Financial Services Advisors
Florida
$98K +$1.01K +5 +1%
Cambridge Investment Research Advisors
14
Cambridge Investment Research Advisors
Iowa
$94K – – –
SWM
15
SeaCrest Wealth Management
New York
$88K – – –
HighTower Advisors
16
HighTower Advisors
Illinois
$82K -$52.7K -261 -39%
Rockefeller Capital Management
17
Rockefeller Capital Management
New York
$80K – – –
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$73K +$73.1K +362 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$56K +$4.64K +23 +9%
AWA
20
Arkadios Wealth Advisors
Georgia
$43K +$43.6K +216 New
CAPTRUST Financial Advisors
21
CAPTRUST Financial Advisors
North Carolina
$40K – – –
AGM
22
Alpine Global Management
New York
$38K +$38K +188 New
LPL Financial
23
LPL Financial
California
$33K -$1.01K -5 -3%
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$32K +$31.9K +158 New
Bank of America
25
Bank of America
North Carolina
$31K +$1.41K +7 +5%
1
2

AIM Hedge Fund Activity: Q3 2021 in Review

36 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q3 2021, worth a combined $14.7M — down 4.8% from $15.5M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new AIM positions and 5 closed out — a net gain of 1 holder — while 12 added to existing stakes and 5 trimmed.

The largest buyer was Dimensional Fund Advisors, adding an estimated $468K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $329K sold.

  • 36 institutional investors held AIM ImmunoTech (AIM) as of Q3 2021, up from 35 in Q2 2021.
  • Funds reported $14.7M of AIM ImmunoTech stock for Q3 2021, down 4.8% quarter-over-quarter.
  • 6 funds opened new AIM ImmunoTech positions in Q3 2021 and 5 closed out, a net change of +1 holder.
  • The largest AIM ImmunoTech buyer in Q3 2021 was Dimensional Fund Advisors, an estimated $468K added.
  • The largest AIM ImmunoTech seller in Q3 2021 was Renaissance Technologies, an estimated $329K sold.

Based on aggregated 13F filings for Q3 2021.